Bioprocessing Q3: After 18 challenging months, is the worst behind?

Retrieved on: 2024-10-24 18:30:34

Tags for this article:

Sartorius

Thermo Fisher Scientific

Repligen

MBE

Click the tags to see associated articles and topics

Bioprocessing Q3: After 18 challenging months, is the worst behind?. View article details on hiswai:

Summary

The article discusses the impact of COVID vaccine demand on the bioprocessing industry, reporting that companies like Sartorius, Thermo Fisher, and Repligen experienced initial growth but faced declines due to reduced vaccine demand and biotech funding.

Article found on: www.bioprocessintl.com

View Original Article